| ASSET | YEAR | % RETURN |
|---|---|---|
GeneDx (WGS) | 2024 | 2,746.67% |
Bright Minds Biosciences (DRUG) | 2024 | 2,317.45% |
Quantum Computing (QUBT) | 2024 | 1,681.49% |
Red Cat (RCAT) | 2024 | 1,343.82% |
Power Solutions International, Inc Common Stock (PSIX) | 2024 | 1,337.2% |
Monopar Therapeutics (MNPR) | 2024 | 1,229.31% |
Mesoblast (MESO) | 2024 | 816.67% |
Quantum (QMCO) | 2024 | 670.29% |
United States Antimony (UAMY) | 2024 | 608% |
Root (ROOT) | 2024 | 596.64% |
Nano Nuclear Energy Inc Common Stock (NNE) | 2024 | 591.53% |
POET Technologies (POET) | 2024 | 489.11% |
Candel Therapeutics (CADL) | 2024 | 482.55% |
TheRealReal (REAL) | 2024 | 452.02% |
Goldgroup Mining (GORO) | 2024 | 450% |
SEALSQ (LAES) | 2024 | 412.5% |
Rezolute (RZLT) | 2024 | 405.15% |
Janux Therapeutics (JANX) | 2024 | 401.31% |
BTQ Technologies Corp Common Stock (BTQ) | 2024 | 358.33% |
Willis Lease Finance (WLFC) | 2024 | 349.75% |
Eos Energy Enterprises (EOSE) | 2024 | 337.84% |
Unusual Machines (UMAC) | 2024 | 320.5% |
Emergent Biosolutions (EBS) | 2024 | 306.81% |
Benitec Biopharma (BNTC) | 2024 | 293.46% |
Grupo Supervielle (SUPV) | 2024 | 283.3% |
Small-cap stocks are treated as having a market cap between $300M and $2B.